Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer

Clinical trial NCT03649321 · TERMINATED

Trial details

NCT number: NCT03649321
Sponsor: University of Texas Southwestern Medical Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of Pancreas

Start date: 2019-01-03
Primary completion: 2022-06-27
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.